Form 4: Genasys CEO Richard Danforth Acquires 200,000 Stock Options
SEC Form 4 Filing
Genasys CEO Richard Danforth was granted options to purchase 200,000 shares of common stock on October 3, 2024.
Summary
- Richard Danforth, CEO of Genasys Inc., was granted options to purchase 200,000 shares of the company's common stock.
- The options were granted on October 3, 2024, with an exercise price of $3.55 per share.
- The options vest in two equal tranches: half on October 3, 2025, and the remaining half on October 3, 2026.
- The options expire on October 3, 2031.
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management and shareholder interests. There are no negative implications.
Positives
- The grant of stock options to the CEO aligns his interests with those of the shareholders.
- The vesting schedule encourages long-term performance and commitment from the CEO.
Risks
- The value of the options is dependent on the future performance of Genasys stock.
- If the stock price does not increase above the exercise price, the options will have no value.
Future Outlook
The vesting schedule of the options suggests a focus on long-term performance and value creation for the company.
Industry Context
Stock option grants are a common form of executive compensation in publicly traded companies, designed to align management's interests with those of shareholders.
Comparison to Industry Standards
- Stock option grants are a standard practice for executive compensation across various industries.
- The vesting schedule of 1/2 after one year and 1/2 after two years is a common vesting schedule for stock options.
- The exercise price of $3.55 is a fixed price at the time of the grant, and the value of the options will depend on the future stock price of Genasys.
Stakeholder Impact
- Shareholders may view the stock option grant positively as it incentivizes the CEO to increase the company's value.
- Employees may see this as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 10/03/2024 | Date of the stock option grant to Richard Danforth. |
| 10/03/2025 | Date when half of the stock options vest. |
| 10/03/2026 | Date when the remaining half of the stock options vest. |
| 10/03/2031 | Expiration date of the stock options. |
Keywords
stock options, executive compensation, insider trading, Genasys, GNSS, Richard Danforth
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.